Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 18,242	$ 7,886	$ 42,174	$ 16,908
General and administrative	5,242	4,752	15,184	10,022
Total operating expenses	23,484	12,638	57,358	26,930
Loss from operations	(23,484)	(12,638)	(57,358)	(26,930)
Interest and other income (expense), net	594	32	844	73
Net loss	(22,890)	(12,606)	(56,514)	(26,857)
Other comprehensive loss:
Unrealized gain (loss) on investments, net	4		(3)	2
Comprehensive loss	$ (22,886)	$ (12,606)	$ (56,517)	$ (26,855)
Net loss per common share, basic	$ (0.78)	$ (0.43)	$ (1.93)	$ (1.21)
Net loss per common share, diluted	$ (0.78)	$ (0.43)	$ (1.93)	$ (1.21)
Weighted-average number of common shares used to compute basic net loss per common share	29,319,042	29,001,213	29,214,549	22,105,321
Weighted-average number of common shares used to compute diluted net loss per common share	29,319,042	29,001,213	29,214,549	22,105,321